Juvenal Tobin W, Castle Biosciences’ Chief Commercial Officer, sold 6,600 shares across two transactions priced from $32.32 to $35.14 per share. The transactions left him with 58,584 shares, a holding stated as about 10.1% of his prior shares, giving investors a specific view of the reported post-sale ownership.
Key Highlights
- The transactions occurred on Sep 14 and Sep 15, 2026.
- Both sales used transaction code S, which identifies open-market sales.
- The post-transaction holding represented about 10.1% of Juvenal Tobin W’s prior shares holding.
CASTLE BIOSCIENCES INC (NASDAQ: CSTL) Chief Commercial Officer Juvenal Tobin W sold 6,600 shares across two transactions at prices ranging from $32.32 to $35.14 per share. The sales left him holding 58,584 shares.
The transactions were completed on Sep 14 and Sep 15, 2026. Both carried transaction code S, the classification used for open-market sales. The reported prices covered a range from $32.32 to $35.14 per share. Juvenal Tobin W was identified as Castle Biosciences’ Chief Commercial Officer.
Reported Holding After the Transactions
The stated post-transaction balance was 58,584 shares. That figure represented about 10.1% of Juvenal Tobin W’s prior shares holding. The reported percentage places the sale against his earlier ownership balance without changing the stated post-transaction share count.
FAQs
Q: How many Castle Biosciences shares did Juvenal Tobin W sell?
A: Juvenal Tobin W sold 6,600 Castle Biosciences shares. The sales occurred across two transactions priced between $32.32 and $35.14 per share.
Q: What was Juvenal Tobin W’s role at Castle Biosciences?
A: Juvenal Tobin W was identified as Castle Biosciences’ Chief Commercial Officer. His reported transactions involved the company’s shares.
Q: How many shares did Juvenal Tobin W own after the sale?
A: Juvenal Tobin W held 58,584 Castle Biosciences shares after the transactions. The reported balance represented about 10.1% of his prior shares holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.